Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP+) as a carrier
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 50, 116466
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874296)
This publication has 32 references indexed in Scilit:
- Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expressionNeoplasma, 2014
- Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3PT platinum-resistant human ovarian cancer cellsOncology Letters, 2013
- Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expressionPharmaceutical Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Mitochondrial and energy metabolism‐related properties as novel indicators of lung cancer stem cellsInternational Journal of Cancer, 2011
- Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-AblBioorganic & Medicinal Chemistry, 2010
- Small mitochondria-targeting molecules as anti-cancer agentsMolecular Aspects of Medicine, 2010
- A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer GrowthCancer Cell, 2007
- Selective Targeting of a Redox-active Ubiquinone to Mitochondria within CellsJournal of Biological Chemistry, 2001
- Tumor inhibitors. LXXIV. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordiiJournal of the American Chemical Society, 1972